Vivos Therapeutics, Inc. (VVOS) is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep apnea and related health issues. The company is headquartered in Denver, Colorado, United States. Vivos’ primary product is The Vivos System, a groundbreaking clinical breakthrough in sleep apnea treatment.
Sleep apnea, a condition that causes intermittent disruptions in breathing during sleep, can lead to serious health complications if not properly managed, including stroke, heart disease, high blood pressure, and diabetes. Vivos Therapeutics’ approach to treating sleep apnea goes beyond managing the symptoms and attempts to treat the root cause of the problem through a system of treatment protocols involving custom-made, oral appliances.
The Vivos System is quite unique compared to traditional sleep apnea treatments, like continuous positive airway pressure (CPAP) machines. The system uses a patient-specific, multi-disciplinary treatment protocol that, according to Vivos, can remodel and enhance the airway, ruling out the need for mechanical devices during sleep or surgical interventions.
Vivos Therapeutics prides itself on a forward-thinking, science-backed approach. The company goes the extra mile to not only provide patients with their patented treatment but also offers comprehensive guidance, taking into account that every patient's experience with sleep apnea may not be the same.
The company is well-respected in the medical tech community for its work in sleep apnea research and treatment, with numerous dental healthcare professionals around the world having been trained and certified as Vivos-trained healthcare providers. In addition, Vivos is committed to continuously improving their products and services through scientific research and innovative technology, underscoring their primary objective of improving the quality of life for patients suffering from sleep-disordered breathing.
Publicly traded as VVOS on the Nasdaq, Vivos Therapeutics continues to make significant strides in the fight against sleep apnea, representing a dynamic and innovative presence in the healthcare technology market. The corporation is playing a crucial role in transforming the lives of those afflicted with sleep apnea, by not only revolutionizing how the disorder is treated but also crafting an approach aimed at achieving a long-term resolution.